Sousa Giovana D, Kishishita Juliana, Aquino Kátia A S, Presgrave Octávio A F, Leal Leila B, Santana Davi P
Department of Pharmaceutical Sciences, Federal University of Pernambuco, Recife, Brazil.
Department of Nuclear Energy, Federal University of Pernambuco, Recife, Brazil.
AAPS PharmSciTech. 2017 Jul;18(5):1833-1842. doi: 10.1208/s12249-016-0663-3. Epub 2016 Nov 10.
The aim of this study was to compare the biopharmaceutical characteristics and irritation potentials of microemulsions (MEs) and conventional systems (CSs) containing oil from Syagrus cearensis for topical delivery of Amphotericin B (AmB). Pseudo-ternary phase diagrams were constructed using a water titration method to develop the MEs, and the CSs were prepared according to the classical technique of phase inversion. In the skin permeation and retention study, dermatomed pig skin without stratum corneum was used as an alternative disturbed skin model. The irritation potential was evaluated using three different methods, chorioallantoic membrane assays (HET-CAM and CAM-TBS), and bovine corneal opacity and permeability (BCOP) test. The optimized formulation (ME1) consisting of 0.1% (w/w) Amphotericin B, 9.1% (w/w) catolé oil, 81% (w/w) Smix (1:1, Tween 20 and Kolliphor EL) possessed droplet size of 31.02 ± 0.9 nm, zeta potential of -23.4 mV, and viscosity 0.63 ± 0.1 Pa.s. ME1 exhibited greater retention of AmB in to skin layers (84.79 ± 2.08 μg cm) than all the others formulations. In general, MEs showed higher drug release and retention than CSs and all of the formulations showed greater retentivity than permeability. Only MEs developed using Labrasol/Plurol Oleique (L/PO) as the surfactant and co-surfactant exhibited a moderate irritation potential; all other MEs and CSs were classified as non-irritants or slight irritants. The results indicate that formulations containing oil from S. cearensis are promising alternatives for the delivery of AmB targeting the treatment of cutaneous leishmaniasis.
本研究的目的是比较含有西阿拉棕果油用于两性霉素B(AmB)局部给药的微乳剂(MEs)和传统体系(CSs)的生物药剂学特性及刺激潜力。采用水滴定法构建伪三元相图以制备MEs,CSs则根据经典的相转变技术制备。在皮肤渗透和滞留研究中,使用无角质层的猪皮作为替代的受损皮肤模型。使用三种不同方法评估刺激潜力,即绒毛尿囊膜试验(HET-CAM和CAM-TBS)以及牛角膜混浊和通透性(BCOP)试验。由0.1%(w/w)两性霉素B、9.1%(w/w)卡托雷油、81%(w/w)Smix(1:1,吐温20和聚氧乙烯氢化蓖麻油EL)组成的优化制剂(ME1)液滴尺寸为31.02±0.9 nm,ζ电位为-23.4 mV,粘度为0.63±0.1 Pa·s。ME1在皮肤层中的AmB滞留量(84.79±2.08 μg/cm)比所有其他制剂都高。总体而言,MEs显示出比CSs更高的药物释放和滞留,并且所有制剂的滞留性均大于渗透性。仅以Labrasol/聚甘油油酸酯(L/PO)作为表面活性剂和助表面活性剂制备的MEs表现出中等刺激潜力;所有其他MEs和CSs均被归类为无刺激物或轻度刺激物。结果表明,含有西阿拉棕果油的制剂是靶向治疗皮肤利什曼病的AmB给药的有前景的替代方案。
Colloids Surf B Biointerfaces. 2008-10-15
AAPS PharmSciTech. 2017-7
Drug Dev Ind Pharm. 2013-4-29
Int J Pharm. 2013-5-31
AAPS PharmSciTech. 2021-4-6
Pharm Dev Technol. 2016-12
Pharmaceutics. 2022-4-22
Evid Based Complement Alternat Med. 2021-8-19